Healthcare entity
Weiss Ratings is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. They are less corroborated than the beat average, carrying 2 original sources each against 4.1 for the same window. Across a 27-day span, the pace is roughly 0.5 stories per week.
Last mentioned: Aug 16, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Weiss Ratings is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. They are less corroborated than the beat average, carrying 2 original sources each against 4.1 for the same window. Across a 27-day span, the pace is roughly 0.5 stories per week. The 5 average consequence score is below the beat benchmark of 6.2 in the same window. Coverage clusters in health-it, which accounts for 1 of those 2, with the remainder spread across 1 other category. We currently track 2 Healthcare stories that mention JPMorgan Chase & Co., published between July 10, 2026 and August 5, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 235 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering JPMorgan Chase & Co.. Shared-story counts are live from our verified record — not editorial picks.
Teva Pharmaceutical's FY2026 EPS guidance fell short of the $2.17 consensus, while revenue projections of $16.5-$16.9B matched expectations. For healthcare leaders, the miss underscores ongoing generic drug pricing pressures and the importance of a diversified pipeline.
Analyst downgrades reflect growing fears that GLP-1 weight loss drugs could erode the sleep apnea device market, even as ResMed’s financials stay solid. The contrast between a $225 low target and $321 high target underscores sector uncertainty.
JPMorgan Chase & Co. is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
